close
Add to watchlist
Hansen Medical Inc (HNSN)
Hansen Medical, Inc. develops, manufactures, and markets medical robotics designed for accurate positioning, manipulation, and stable control of catheters and catheter-based technologies. It focuses on electrophysiology procedures for the diagnosis and treatment of patients, who suffer from abnormal heart rhythms, or arrhythmias, such as atrial fibrillation. The company offers Sensei Robotic Catheter system, which is designed to allow physicians to navigate flexible catheters with stability and control in interventional procedures; disposable Artisan catheter and guide catheter assembly, which consists of a telescoping set of control catheters that are integrated to provide the desired motion of the tip of a diagnostic or therapeutic catheter; and CoHesion 3D Visualization Module, a software interface between its Sensei system and the St. Jude Medical EnSite system to provide physicians with 3D visualization to move a catheter in heart, as well as increase control over placement of the catheter in specific locations. It serves patients, physicians, hospitals, and third-party payors. The company sells its products through direct sales force in the United States; and through direct sales force and distributors primarily in the European Union, as well as internationally. The company has a joint development agreement and a co-marketing agreement with Atrial Fibrillation Division of St. Jude Medical, Inc.; and collaboration agreements with Royal Philips Electronics and GE Healthcare Ltd. Hansen Medical, Inc., formerly known as AutoCath, Inc., was founded in 2002 and is headquartered in Mountain View, California.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 3.04 |
| Volume | 150021 |
| Volume Avg | 545852 |
| 52 Week High | 5.28 |
| 52 Week Low | 1.92 |
| PE | N/A |
| PE (group average) | N/A |
| EPS Year | -0.30 |
| EPS change Q/Q | -13.04% |
| EPS change Q/Q Yr ago | -35.48% |
| EPS change Q/Q next Q est | -33.33% |
| EPS change Y/Y | -114.67% |
| REV change Q/Q | 0% |
| REV change Q/Q Yr ago | -51.39% |
| EPS next Q est | -0.15 |
| EPS next Y est | -0.46 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |